TPT 0701
Alternative Names: TPT-0701Latest Information Update: 04 Mar 2024
At a glance
- Originator Tetra Pharm Technologies
- Class Obesity therapies
- Mechanism of Action Cannabinoid receptor CB1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Obesity